Apogem Capital’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
RSCM
DCP
Apogem Capital's AGL Position: Q2 2022 in Review
Apogem Capital sold out of Agilon Health (AGL) in Q2 2022, closing a stake of 412 shares — an estimated $261K sold.
Apogem Capital first reported a position in AGL in Q3 2021 and held it in 3 quarters. The position peaked at $304K in Q4 2021. 148 funds tracked by Wall St. Rank hold AGL as of Q2 2022.
- Apogem Capital reported no remaining Agilon Health position as of Q2 2022 after selling out during the quarter.
- Apogem Capital sold 412 Agilon Health shares in Q2 2022, an estimated $261K.
- Apogem Capital first reported a position in Agilon Health in Q3 2021 and held it in 3 quarters.
- Apogem Capital's Agilon Health position peaked at $304K in Q4 2021.
- 148 funds tracked by Wall St. Rank held Agilon Health as of Q2 2022.
Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.